Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Integrative tumor board: Recurrent lymphoma

April Yuning Feng1, Sigrun Hallmeyer, David Peace

  • 1Block Center for Integrative Cancer Care, 1800 Sherman, Suite 515, Evanston, IL 60201, USA. ayfeng@blockmedical.com

Integrative Cancer Therapies
|August 18, 2004
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bloodless heart transplantation in patients who refuse transfusion: An 11-year case series.

The Journal of thoracic and cardiovascular surgery·2025
Same author

A Nature-Based Intervention for Promoting Physical Activity in Older Adults: A Qualitative Study Using the COM-B Model.

International journal of environmental research and public health·2024
Same author

Cannabis and Cannabinoids in Adults With Cancer: ASCO Guideline.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2024
Same author

Durvalumab and guadecitabine in advanced clear cell renal cell carcinoma: results from the phase Ib/II study BTCRC-GU16-043.

Nature communications·2024
Same author

Real-world outcomes with immuno-oncology therapies in advanced melanoma: final results of the OPTIMIzE registry study.

Immunotherapy·2023
Same author

Characteristics of patients with hematologic malignancies without seroconversion post-COVID-19 third vaccine dosing.

Biology methods & protocols·2023